Relmada Therapeutics, Inc. (RLMD)
4.42
+0.28
(+6.76%)
USD |
NASDAQ |
Dec 10, 16:00
4.50
+0.08
(+1.81%)
After-Hours: 20:00
Relmada Therapeutics Market Cap: 324.13M for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Puma Biotechnology, Inc. | 281.69M |
| Sensus Healthcare, Inc. | 65.70M |
| NovaBay Pharmaceuticals, Inc. | 304.95M |
| Palatin Technologies, Inc. | 23.82M |
| Theriva Biologics, Inc. | 7.473M |
Market Cap Related Metrics
| Price to Book Value | 34.24 |
| Price | 4.42 |
| Earnings Yield | -40.66% |